Transgenic overexpression of constitutively active AKT1 and AKT2 in oncogene-driven mouse models of breast cancer have revealed their opposing effects on cell migration and tumour metastasis, whereby AKT1 inhibits but AKT2 promotes the establishment of metastatic lesions [64,65,73]. This evidence concerns the gene AKT2 and breast carcinoma.